Results 201 to 210 of about 31,301 (241)

Head and neck squamous cell carcinoma in childhood

Medical and Pediatric Oncology, 1998
Squamous cell carcinoma (SCC) of the head and neck region is rare in young patients and even less frequent in children 15 years or younger children. The patients reported in the literature are isolated cases and their management is always difficult because there is no large experience or a convincing theory to support treatment decisions for every ...
M B, de Carvalho, J de A, Sobrinho, A, Rapoport, A S, Fava, A F, Mendes, J L, Kanda, C N, Lehn, J, Chacra Júnior, M B, Menezes, F, Walder, S A, Franzi   +10 more
openaire   +2 more sources

The coagulome of Head and Neck Squamous Cell Carcinoma

Oral Oncology, 2021
International ...
Zuzana Saidak, Antoine Galmiche, Marine Lottin, Lydia Montes, Simon Soudet, Marie-Antoinette Sevestre, Florian Clatot, Haitham Mirghani   +7 more
openaire   +3 more sources

Basaloid squamous cell carcinoma of the head and neck

Current Opinion in Otolaryngology & Head and Neck Surgery, 2004
Basaloid squamous cell carcinoma is an uncommon variant of squamous cell carcinoma and was first described as a distinct entity in 1986. Basaloid squamous cell carcinoma seems to have a poorer survival rate than classical squamous cell carcinoma. On the basis of a critical literature survey, we attempt to evaluate if basaloid squamous cell carcinoma is
Zbären P, Nuyens M, Stauffer E
openaire   +3 more sources

Cetuximab In Squamous Cell Carcinoma of the Head and Neck

Future Oncology, 2006
Surgery and radiotherapy are the standard treatment options for patients with squamous cell carcinoma of the head and neck (SCCHN). Chemotherapy and chemoradiotherapy are new alternatives for locally advanced disease, particularly induction chemotherapy for patients with unresectable tumors.
Ricardo, Hitt, Patricia, Martín, Manuel, Hidalgo   +2 more
openaire   +2 more sources

Squamous cell carcinoma of the head and neck in children

International Journal of Pediatric Otorhinolaryngology, 2019
To discuss the presentation, evaluation, and management of squamous cell carcinoma of the head and neck in the pediatric population.Medical records of pediatric (≤20 years) patients treated for squamous cell carcinoma of the head and neck between 1996 and 2016 were reviewed.
Natasha D. Dombrowski, Nikolaus E. Wolter, Alexandria L. Irace, Caroline D. Robson, Antonio R. Perez-Atayde, Jennifer W. Mack, Reza Rahbar   +6 more
openaire   +2 more sources

Angiogenesis in head and neck squamous cell carcinoma

Clinical Otolaryngology and Allied Sciences, 2000
Tumour angiogenesis has recently attracted a great deal of attention as a critical part of oncogenesis and a necessary prerequisite for a malignant phenotype. Research into this process not only offers new insights into tumour biology but is also leading to the development of realistic novel and minimally toxic anti-tumour therapies.
J J, Homer, J, Greenman, N D, Stafford
openaire   +2 more sources

Afatinib in squamous cell carcinoma of the head and neck

Expert Opinion on Pharmacotherapy, 2016
Recently new data on the efficacy of afatinib in head and neck squamous cell carcinoma (HNSCC) have been published.We searched the literature for published and ongoing studies with afatinib in HNSCC. Phase I data and results of phase II and III studies of afatinib in HNSCC are discussed.
Specenier, Pol, Vermorken, Jan
openaire   +3 more sources

The economics of squamous cell carcinoma of the head and neck

Current Opinion in Otolaryngology & Head & Neck Surgery, 2007
The current review presents a brief overview of the recent literature on the costs of squamous cell carcinoma of the head and neck (SCCHN), one of the most common forms of cancer. SCCHN is a relatively deadly disease. Approximately 50% of patients survive to 5 years, and surgery and chemoradiotherapy can leave survivors with pain, disfigurement, and ...
Joseph, Menzin, Lisa M, Lines, Lauren N, Manning   +2 more
openaire   +2 more sources

Pharmacotherapy of head and neck squamous cell carcinoma

Expert Opinion on Pharmacotherapy, 2009
The clinical management of locally advanced head and neck squamous cell carcinoma (HNSCC) is a challenging problem and requires a multidisciplinary approach. Historically, locally advanced HNSCC has been primarily managed with surgery and radiation (RT).
Quintin, Pan, Michael A, Gorin, Theodoros N, Teknos   +2 more
openaire   +2 more sources

Pharmacotherapy for squamous-cell carcinoma of the head and neck

Expert Opinion on Pharmacotherapy, 2011
squamous-cell carcinoma of the head and neck (HNSCC) is one of the most common malignancies, the treatment of which constitutes a therapeutic challenge.the purpose of this review is to provide an update on the pharmacotherapy for the treatment of HNSCC focusing mainly on molecular-targeted therapies.
Giorgos, Papaspyrou, Jochen A, Werner, Andreas, Dietz   +2 more
openaire   +2 more sources